Results 151 to 160 of about 4,979,977 (315)

Lipoprotein(a), ABO Blood Types and Clinical Outcomes: Novel Findings and Clinical Implications in Patients With Chronic Coronary Syndrome

MedComm
This study aimed to investigate the effect of lipoprotein(a) (Lp(a)) on major adverse cardiovascular events (MACEs) among individuals with chronic coronary syndrome (CCS) according to ABO blood groups.
Hui‐Hui Liu, Chen‐Xi Song, Sha Li, Yan Zhang, Dong Yin, Wei‐Hua Song, Yuan‐Lin Guo, Cheng‐Gang Zhu, Na‐Qiong Wu, Rui‐Xia Xu, Qian Dong, Jie Qian, Yu‐Hui Zhang, Ke‐Fei Dou, Jian‐Jun Li   +14 more
doaj   +1 more source

Physical Fitness and Cardiometabolic Disease

Reviews in Cardiovascular Medicine, 2022
Peter Kokkinos, Jonathan Myers
openaire   +3 more sources

Walking the VLDL tightrope in cardiometabolic diseases

Trends in Endocrinology & Metabolism
Very-low-density lipoprotein (VLDL), a triglyceride-rich lipoprotein secreted by hepatocytes, is pivotal for supplying peripheral tissues with fatty acids for energy production. As if walking on a tightrope, perturbations in the balance of VLDL metabolism contribute to cardiometabolic dysfunction, promoting pathologies such as cardiovascular disease ...
Mindy Kim, Ze Zheng
openaire   +3 more sources

Monitoring and assessment for obstructive sleep apnea

FlexMat, EarlyView.
This review systematically classifies Obstructive Sleep Apnea (OSA) monitoring indicators into three categories: physical, biochemical, and electrophysiological indicators, and lists several methods for each category. Abstract Obstructive sleep apnea (OSA) is a common chronic sleep‐disordered breathing disease characterized by recurrent upper airway ...
Yaowen Xu, Feifei Lin, Shujiao Chen, Zhen You, Shujing Zhu, Weiwei Zhao, Qiang Zhao   +6 more
wiley   +1 more source

Ectopic adiposity and cardiometabolic health in COPD

, 2018
Valérie Coats,1 Jean-Pierre Després,1 Natalie Alméras,1 Mickaël Martin,1 Don D Sin,2 Rémi Rabasa-Lhoret,3 Éric Larose,1 Wan C Tan,2 Jean Bourbeau,4 François Maltais1On behalf of the CanCOLD Collaborative ...
Coats V, Rabasa-Lhoret R, Sin DD, Maltais F, Alméras N, Bourbeau J, Larose E, Després JP, Martin M, Tan WC   +9 more
core  

Physicochemical, Functional, and Health‐Promoting Properties of Processed Nettle (Urtica Dioica) Leaves: A Review

Future Postharvest and Food, EarlyView.
Stinging nettle (Urtica dioica L.) leaves are a nutrient‐dense source of proteins, dietary fiber, chlorophylls, carotenoids, and phenolic compounds. Processing technologies enable the production of powders and extracts for incorporation into bakery, beverage, dairy, and nutraceutical products; however, challenges remain regarding sensory quality ...
Mary Nkongho Tanyitiku, Rakshya Pandit, Mihiri Vanniarachchy   +2 more
wiley   +1 more source

Syncing Health Timing: Exploring the Interplay of Circadian Rhythms, Obesity, and Cardiovascular Diseases

Food Safety and Health, EarlyView.
Circadian rhythm disruption impairs metabolic regulation, appetite control, and vascular function, promoting obesity and cardiovascular diseases. Evidence highlights a bidirectional relationship where metabolic disorders further disturb circadian timing.
Ghizal Fatima, István Dalmadi, Anna Jánosi, Krisztina Takács, Eszter Halmy   +4 more
wiley   +1 more source

Identifying Postpartum Intervention Approaches to Reduce Cardiometabolic Risk Among American Indian Women With Prior Gestational Diabetes, Oklahoma, 2012–2013

, 2015
Introduction: Innovative approaches are needed to reduce cardiometabolic risk among American Indian women with a history of gestational diabetes. We assessed beliefs of Oklahoma American Indian women about preventing type 2 diabetes and cardiovascular ...
Jones, Emily J., Peercy, Michael, Parker, Stephany P., McCage, Shondra, Nicklas, Jacinda M., Levkoff, Sue, Seely, Ellen, Woods, J. Cedric, Jackson, Teresa, Mata, Sara A.   +9 more
core   +1 more source

Targeting vascular adhesion protein-1 and myeloperoxidase with a dual inhibitor SNT-8370 in preclinical models of inflammatory disease

Nature Communications
Inflammatory diseases are a major source of morbidity and mortality world-wide, the pathogenesis of which are characterised by the interplay of key pro-inflammatory and oxidative enzymes. Here, we report the development of a small molecule dual inhibitor
Elias Glaros, Jonathan Foot, Ben Rayner, Heidi Schilter, Yunjia Zhang, Martina Paumann-Page, Mauro M. Teixeira, Wolfgang Jarolimek, Shane R. Thomas   +8 more
doaj   +1 more source

Cardiometabolic medicine in China: Burden, challenges, and strategic priorities

Metabolism Open
The development of cardiometabolic medicine (CMM) reflects a shift in cardiovascular disease (CVD) management from organ-based care toward greater cross-system integration.
Rui-Xiang Zeng, Sha Li, Xiao Wang, Ke-Fei Dou, Jian-Jun Li   +4 more
doaj   +1 more source